(Q28239710)

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

High frequencies of alpha-thalassaemia are the result of natural selection by malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Genetic and environmental influences on premature death in adult adoptees

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Innate immunity: the virtues of a nonclonal system of recognition

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Host cell-pathogen interface: molecular mechanisms and genetics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Toll-like receptors and innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Toll-like receptors in innate immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

The Toll gene of Drosophila, required for dorsal-ventral embryonic polarity, appears to encode a transmembrane protein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Toll-like receptor-2 mediates lipopolysaccharide-induced cellular signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Human toll-like receptor 2 confers responsiveness to bacterial lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Toll-like receptor 2 functions as a pattern recognition receptor for diverse bacterial products.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

A structural basis of the interactions between leucine-rich repeats and protein ligands

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Unresponsiveness of MyD88-deficient mice to endotoxin

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

The Toll-IL-1 receptor adaptor family grows to five members.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Of mice and men: species variations of Toll-like receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Structure and function of lipopolysaccharide binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

CD14, a receptor for complexes of lipopolysaccharide (LPS) and LPS binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

The interface between innate and adaptive immunity

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

MD-2, a molecule that confers lipopolysaccharide responsiveness on Toll-like receptor 4

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Identification of Lps2 as a key transducer of MyD88-independent TIR signalling

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Role of adaptor TRIF in the MyD88-independent toll-like receptor signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

LPS-TLR4 signaling to IRF-3/7 and NF-kappaB involves the toll adapters TRAM and TRIF

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

TRAM is specifically involved in the Toll-like receptor 4-mediated MyD88-independent signaling pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Toll-like receptor downstream signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Lipoteichoic acid (LTA) of Streptococcus pneumoniae and Staphylococcus aureus activates immune cells via Toll-like receptor (TLR)-2, lipopolysaccharide-binding protein (LBP), and CD14, whereas TLR-4 and MD-2 are not involved

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Recognition of pneumococcal peptidoglycan: an expanded, pivotal role for LPS binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Lipopolysaccharide binding protein binds to triacylated and diacylated lipopeptides and mediates innate immune responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Nuclear DNA analyses in genetic studies of populations: practice, problems and prospects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Single-nucleotide polymorphisms in the public domain: how useful are they?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

A map of human genome sequence variation containing 1.42 million single nucleotide polymorphisms

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

A genomic polymorphism within the tumor necrosis factor locus influences plasma tumor necrosis factor-alpha concentrations and outcome of patients with severe sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

CD14 and toll-like receptor 4: a link between infection and acute coronary events?

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

LPS-binding protein protects mice from septic shock caused by LPS or gram-negative bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Inhibition of LPS-induced activation of alveolar macrophages by high concentrations of LPS-binding protein

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

High concentrations of lipopolysaccharide-binding protein in serum of patients with severe sepsis or septic shock inhibit the lipopolysaccharide response in human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Gene variants of the bactericidal/permeability increasing protein and lipopolysaccharide binding protein in sepsis patients: gender-specific genetic predisposition to sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Polymorphisms in the lipopolysaccharide-binding protein and bactericidal/permeability-increasing protein in patients with myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

A coding mutation within the first exon of the human MD-2 gene results in decreased lipopolysaccharide-induced signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Nod2, a Nod1/Apaf-1 family member that is restricted to monocytes and activates NF-kappaB

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Nod2 is a general sensor of peptidoglycan through muramyl dipeptide (MDP) detection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Host recognition of bacterial muramyl dipeptide mediated through NOD2. Implications for Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Nod1 detects a unique muropeptide from gram-negative bacterial peptidoglycan

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Nucleotide-binding oligomerization domain proteins are innate immune receptors for internalized Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

A frameshift mutation in NOD2 associated with susceptibility to Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Association between insertion mutation in NOD2 gene and Crohn's disease in German and British populations

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Mapping of a susceptibility locus for Crohn's disease on chromosome 16

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Association of NOD2 leucine-rich repeat variants with susceptibility to Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Grain dust, endotoxin, and airflow obstruction

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Effect of inhaled endotoxin on bronchial reactivity in asthmatic and normal subjects

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Variable airway responsiveness to inhaled lipopolysaccharide

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

TLR4 mutations are associated with endotoxin hyporesponsiveness in humans

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

A functional polymorphism of toll-like receptor 4 is not associated with likelihood or severity of meningococcal disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Variation in Toll-like receptor 4 and susceptibility to group A meningococcal meningitis in Gambian children.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Association between common Toll-like receptor 4 mutations and severe respiratory syncytial virus disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Effects of functional Toll-like receptor-4 mutations on the immune response to human and experimental sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Relevance of mutations in the TLR4 receptor in patients with gram-negative septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Polymorphisms in Toll-like receptor 4 and the systemic inflammatory response syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Human toll-like receptor 4 mutations but not CD14 polymorphisms are associated with an increased risk of gram-negative infections

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Relationship between a toll-like receptor-4 gene polymorphism, bacterial vaginosis-related flora and vaginal cytokine responses in pregnant women

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Association between the Asp299Gly polymorphisms in the Toll-like receptor 4 and premature births in the Finnish population

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Toll-like Receptor 4 Polymorphisms and Atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

TLR4 Asp299Gly polymorphism is not associated with coronary artery stenosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Association of the Toll-like receptor 4 gene Asp299Gly polymorphism with acute coronary events.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Association of hypo-responsive toll-like receptor 4 variants with risk of myocardial infarction*1

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Toll-like receptor 4 Asp299Gly gene polymorphism and risk of atherothrombosis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Asp299Gly and Thr399Ile genotypes of the TLR4 gene are associated with a reduced prevalence of diabetic neuropathy in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

The role of innate immunity in acute allograft rejection after lung transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Toll-like receptors in the pathogenesis of human disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Pattern recognition receptors TLR4 and CD14 mediate response to respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Involvement of toll-like receptor 4 in innate immunity to respiratory syncytial virus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Respiratory syncytial virus-induced activation of nuclear factor-kappaB in the lung involves alveolar macrophages and toll-like receptor 4-dependent pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

TLR signaling: an emerging bridge from innate immunity to atherogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Reduced atherosclerosis in MyD88-null mice links elevated serum cholesterol levels to activation of innate immunity signaling pathways

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Lack of Toll-like receptor 4 or myeloid differentiation factor 88 reduces atherosclerosis and alters plaque phenotype in mice deficient in apolipoprotein E

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Immunopathogenesis of atherosclerosis: endotoxin accelerates atherosclerosis in rabbits on hypercholesterolemic diet

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

In Vivo Evidence for a Role of Toll-Like Receptor 4 in the Development of Intimal Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Toll-like receptor-4 is expressed by macrophages in murine and human lipid-rich atherosclerotic plaques and upregulated by oxidized LDL.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Chlamydia pneumoniae as an emerging risk factor in cardiovascular disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Chlamydial heat shock protein 60 activates macrophages and endothelial cells through Toll-like receptor 4 and MD2 in a MyD88-dependent pathway

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Predominant role of toll-like receptor 2 versus 4 in Chlamydia pneumoniae-induced activation of dendritic cells

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Association of TLR4 mutations and the risk for acute GVHD after HLA-matched-sibling hematopoietic stem cell transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Polymorphisms of the lipopolysaccharide-signaling complex in inflammatory bowel disease: association of a mutation in the Toll-like receptor 4 gene with ulcerative colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Toll-like receptor 4 polymorphism and severity of atopy in asthmatics

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

The Toll-like receptor 4 Asp299Gly functional variant is associated with decreased rheumatoid arthritis disease susceptibility but does not influence disease severity and/or outcome

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Cutting edge: Immune stimulation by neisserial porins is toll-like receptor 2 and MyD88 dependent.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

A lipopolysaccharide-deficient mutant of Neisseria meningitidis elicits attenuated cytokine release by human macrophages and signals via toll-like receptor (TLR) 2 but not via TLR4/MD2.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Single nucleotide polymorphism--disease relationships: statistical issues for the performance of association studies

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Monocytes heterozygous for the Asp299Gly and Thr399Ile mutations in the Toll-like receptor 4 gene show no deficit in lipopolysaccharide signalling.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Heterozygous toll-like receptor 4 polymorphism does not influence lipopolysaccharide-induced cytokine release in human whole blood.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Systemic responsiveness to lipopolysaccharide and polymorphisms in the toll-like receptor 4 gene in human beings.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Assay of locus-specific genetic load implicates rare Toll-like receptor 4 mutations in meningococcal susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Sequence variants of toll-like receptor 4 are associated with prostate cancer risk: results from the CAncer Prostate in Sweden Study.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Rapid and inexpensive real-time PCR for genotyping functional polymorphisms within the Toll-like receptor -2, -4, and -9 genes.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

A novel polymorphism in the toll-like receptor 2 gene and its potential association with staphylococcal infection

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

High frequency of polymorphism Arg753Gln of the Toll-like receptor-2 gene detected by a novel allele-specific PCR

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Lack of association between Toll-like receptor 2 polymorphisms and susceptibility to severe disease caused by Staphylococcus aureus

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

The Arg753GLn polymorphism of the human toll-like receptor 2 gene in tuberculosis disease

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Cutting edge: activation of Toll-like receptor 2 induces a Th2 immune response and promotes experimental asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

The toll-like receptor 2 R753Q polymorphism defines a subgroup of patients with atopic dermatitis having severe phenotype.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Detection of Toll-like receptor 2 (TLR2) mutation in the lepromatous leprosy patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Cutting edge: a Toll-like receptor 2 polymorphism that is associated with lepromatous leprosy is unable to mediate mycobacterial signaling

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

A polymorphism in the toll-like receptor 2 is associated with IL-12 production from monocyte in lepromatous leprosy

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Toll-like receptor 2 Arg677Trp polymorphism is associated with susceptibility to tuberculosis in Tunisian patients

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Toll-like receptor 2 as a major gene for asthma in children of European farmers

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Single-nucleotide polymorphisms in the Toll-like receptor 9 gene (TLR9): frequencies, pairwise linkage disequilibrium, and haplotypes in three U.S. ethnic groups and exploratory case–control disease association studies☆☆This work was supported

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Crohn's disease is associated with a toll-like receptor-9 polymorphism.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Toll-like receptor 9 signaling mediates the anti-inflammatory effects of probiotics in murine experimental colitis.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Toll-like receptor 6 gene (TLR6): single-nucleotide polymorphism frequencies and preliminary association with the diagnosis of asthma

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

TOLL-like receptor 10 genetic variation is associated with asthma in two independent samples.

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

IL10 gene polymorphisms are associated with asthma phenotypes in children

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Role of toll-like receptor 4 mutations in gram-negative septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

Heterozygous toll-like receptor 2 polymorphism does not affect lipoteichoic acid-induced chemokine and inflammatory responses

1 reference

https://api.crossref.org/works/10.1016%2FS1473-3099%2805%2901308-3

7 January 2021

10.1016/S1473-3099(05)01308-3

Identifiers

DOI

1 reference

Consolidated OpenCitations Corpus – April 2017

release_d2wionkqbfe2nicnr2pflnd444

1238424

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/d2wionkqbfe2nicnr2pflnd444

24 November 2022

mapped directly with Wikidata item

1238424

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference